Vitamin D deficiency, secondary hyperparathyroidism and respiratory insufficiency in hospitalized patients with COVID-19

• Published in: Journal of endocrinological investigation Vol. 44; no. 10; pp. 2285 - 2293
• Main Authors: Mazziotti, G., Lavezzi, E., Brunetti, A., Mirani, M., Favacchio, G., Pizzocaro, A., Sandri, M. T., Di Pasquale, A., Voza, A., Ciccarelli, M., Lania, A. G.
• Format: Journal Article
• Language: English
• Published: Cham Springer International Publishing 01.10.2021; Springer Nature B.V
• Subjects: 25-Hydroxyvitamin D; Adult; Aged; Aged, 80 and over; Blood pressure; Calcium; Calcium (blood); Coronaviruses; COVID-19; COVID-19 - blood; COVID-19 - complications; COVID-19 - therapy; Endocrinology; Female; Humans; Hyperparathyroidism; Hyperparathyroidism - blood; Hyperparathyroidism - complications; Inflammation; Internal Medicine; Male; Mechanical ventilation; Medicine; Medicine & Public Health; Metabolic Diseases; Middle Aged; Nutrient deficiency; Original; Original Article; Oxygen; Parathyroid; Parathyroid hormone; Patients; Respiratory Insufficiency - blood; Respiratory Insufficiency - complications; Respiratory Insufficiency - therapy; Retrospective Studies; Risk factors; Severe acute respiratory syndrome coronavirus 2; Treatment Outcome; Ventilation; Vitamin D; Vitamin D Deficiency - blood; Vitamin D Deficiency - complications; Vitamin deficiency; COVID-19; Vitamin D deficiency; Pneumonia; Vitamin D; PTH; SARS-CoV-2 infection; Hyperparathyroidism

Purpose Hypovitaminosis D has emerged as potential risk factor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in the general population with variable effects on the outcome of the coronavirus disease-19 (COVID-19). The aim of this retrospective single-center study was to...